Z-DEVD-FMK is a specific, irreversible Caspase-3 inhibitor, and also shows potent inhibition on caspase-6, caspase-7, caspase-8, and caspase-10.

Pomalidomide is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities.

EVP4593 shows potent inhibitory activity toward both NF-κB activation and TNF-α production with IC50 of 11 nM and 7 nM in Jurkat T cells, respectively.

Nutlin-3 is a potent and selective Mdm2 (RING finger-dependent ubiquitin protein ligase for itself and p53) antagonist.

Sepantronium Bromide is a small-molecule proapoptotic agent with potential antineoplastic activity.

AT406 is a potent Smac mimetic and an antagonist of IAP.

BV-6 is a SMAC mimetic, dual cIAP and XIAP inhibitor.

GSK2606414 is an orally available, potent, and selective PERK inhibitor.